Cisplatin induces radioprotection in human T98G glioma cells

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 1131-1134

  Poppenborg, Heike ^a   Münstermann, Gudrun ^a   Knüpfer, Matthias M ^c   Hotfilder, Marc ^a   Hacker Klom, Ursula ^b   Wolff, Johannes E A ^a,b  

^a Department of Paediatric Haematology ^*  (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Brain tumor; Cell culture; Chemotherapy; Glutathione; Radiation; Resistance

Indexed keywords

CISPLATIN; COBALT 60; GLUTATHIONE;

ARTICLE; CELL GROWTH; COLORIMETRY; CONTROLLED STUDY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PROTECTION; RADIOSENSITIVITY;

EID: 1842403512     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Raaphorst GP, Feeley M, DaSilva VF, Danjoux CE, and Gerig LH: A comparison of heat and radiation sensitivity of three human cell lines: Int J Radiat Oncol Biol Phys 17: 615-622, 1989.
2. Spence AM, Berger MS, Livingston RB, Ali-Osman F, and Griffin B: Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure. J Neurooncol 12: 187-191, 1992.
3. Alvarez MV, Cobreros G, Heras A, and Lopez-Zumel MC: Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer. Br J Cancer-Suppl 37: 68-72, 1978.
4. Dritschilo A, Piro AJ, and Kelman AD: The effect of cis-platinum on the repair of radiation damage in plateau phase Chinese hamster (V79) cells. Int J Radiat Biol Phys 5: 1345-1349, 1979.
5. Douple EB, and Richmond RC: A review of platinum complex biochemistry suggests a rationale for combined platinum radiotherapy. Int J Radiat Oncol Biol Phys 5: 1335-1339, 1979.
6. Britten RA, Evans AJ, Allalunis-Turner J, and Pearcey RG: Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines. Int J Radiat Oncol Biol Phys 34: 367-374, 1996.
7. EORTC Brain Tumour Group: Cisplatin does not enhance the effect of radiation therapy in malignant gliomas. Eur J Cancer 5: 568-571, 1991.
8. Hansen MB, Nielsen SE, and Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119: 203-210, 1989.
9. Tietze F: Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem 27: 502-522, 1969.
10. Schwartz JL, Rotmensch J, Giovanazzi S, Cohen MB, and Weichselbaum RR: Faster repair of DNA double-strand breaks in radioresistant human tumour cells. Int J Radiat Oncol Biol Phys 15: 907-912, 1988.
11. Britten RA, Warenius HM, White R, and Peacock J: BSO-induced reduction of glutathione levels increases the cellular radiosensitivity of drug-resistant human tumour cells. Int J Radiat Oncol Biol Phys 22: 769-772, 1992.
12. Bump EA, Yu NY, and Brown JM: Radiosensitization of hypoxic tumour cells by depletion of intracellular glutathione. Science 217: 544-545, 1982.
13. Teicher BA, Holden SA, Herman TS, Sotomayor EA, Khandekar V, Rosbe KW, Brann TW, Korbut TT, and Frei E III: Characteristics of five human tumor cell lines and sublines resistant to cisdiamminedichloroplatinum (II). Int J Cancer 47: 252-260, 1991.
14. Gately DP, and Howell SB: Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 67: 1171-1176, 1993.
15. Scanlon KJ, Kashani-Sabet M, Tone T, and Funato T: Cisplatin resistance in human cancers. Pharmacol Ther 52: 385-406, 1991.
16. Hrubisko M, McGown AT, and Fox BW: The role of metallothionein, glutathione, glutathione s-transferases and DNA repair in resistance to anticancer platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents. Biochem Pharmacol 45: 2536, 1993.
17. Wolff JEA, Denecke J, and Jürgens H: Dexamethasone induces partial resistance to cisplatinum in C6 glioma cells. Anicancer Research 16: 805-810, 1996.
18. Sorenson CM, Barry MA, and Eastman A: Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 82: 749-755, 1990.
19. Hong JH, Chiang CS, Campbell IL, Sun JR, Withers HR, and McBride WH: Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys 33: 619-626, 1995.
20. Hallahan DE, Beckett MA, Kufe D, and Weichselbaum RR: The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines. Int J Radiat Oncol Biol Phys 19: 69-74, 1990.
21. Friesen C, Herr I, Krammer PH, and Debatin KM: Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Medicine 2: 574-577, 1996.
22. Zhang JG, Zhong LF, Zhang M, and Xia YX: Protection effects of procaine on oxidative stress and toxicities of renal cortical slices from rats caused by cisplatin in vitro. Arch Toxicol 66: 354-358, 1992.